[1]
S. Kruger, “Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104”, AO, vol. 54, no. 7, pp. 993–1000, Aug. 2015.